Chronic kidney disease testing among at-risk adults in the U.S. remains low: Real-world evidence from a national laboratory database

An estimated 37 million Americans have chronic kidney disease (CKD). Nearly 90% do not know about their condition because of low awareness about the importance of CKD testing and diagnosis among practitioners and people at risk for CKD.

Labcorp’s perspective: Responding to SARS-CoV-2 and the next pandemic

The magnitude of the COVID-19 pandemic has tested the limits of the response capacities of governments, public health and healthcare infrastructure, and diagnostic laboratories.

Walgreens expands access to COVID-19 testing services by offering Pixel by Labcorp® At-Home COVID-19 PCR Kits at no cost through curbside and in-store pickup

DEERFIELD, Ill., May 23, 2022 — Walgreens, in collaboration with the U.S. Department of Health and Human Services (HHS) and Labcorp, a leading global life sciences company, today announced a program to make Pixel by Labcorp®[1] COVID-19 at-home PCR collection kits available for curbside and in-store pickup at more than 1,000 stores nationwide. This program is designed to offer customers access to convenient, reliable testing at no cost and with no insurance or eligibility requirements.  This initiative builds on Walgreens collaboration with HHS and Labcorp to offer COVID-19 at-home collection kits nationwide at no cost to individuals who meet clinical guidelines.[2]

Labcorp launches new test for people with skin cancer

BURLINGTON, N.C. --(BUSINESS WIRE)--May 18, 2022-- Finding treatment options for skin cancer may become easier with the launch of a new test by Labcorp (NYSE: LH), a leading global life sciences company.

Labcorp receives emergency use authorization for first non-prescription at-home collection kit for combined COVID-19, flu and RSV detection

BURLINGTON, N.C. --(BUSINESS WIRE)--May 18, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the receipt of of Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined at-home collection kit available that simultaneously detects COVID-19, influenza A/B and respiratory syncytial virus (RSV), a common but contagious respiratory virus often seen in children.